Unpacking the FDA’s Proposed Rule for Laboratory Developed Tests
Recorded
Wednesday, November 8, 2023 · 12:00 p.m.
ABOUT THIS WEBINAR
After years of discussion surrounding public confidence in the reliability of laboratory developed tests (LDTs), the U.S. Food and Drug Administration (FDA) has put forth its own proposal that would upend current regulations by granting the agency oversight of LDTs. If enacted, the proposed rule would phase out the current enforcement discretion approach for LDTs and instead reclassify these tests as in vitro diagnostic (IVD) devices subject to lengthy and potentially costly FDA pre-market reviews.
Join us at 12:00 p.m. EST, Wednesday, Nov. 8, as we welcome attorney Gail H. Javitt of health law firm Hyman, Phelps, and McNamara, and “The FDA Law Blog”, to dive into the specifics of this proposal and how labs stand to be impacted. Although discussion surrounding this rule remains fluid as the FDA seeks additional input from labs and stakeholders, now is the time to ensure your lab understands how your ability to develop and offer LDTs could be affected.
We will review:
• How the current enforcement discretion approach for LDTs would change.
• A timeline for the rollout of the proposal’s five phases.
• Questions surrounding pre-market submissions and test complexity.
• How labs can offer public comments and input.
• Q&A
Business & finance
Science & tech
ADDITIONAL INFO
Categories:
Business & finance
Science & tech
When:
Wednesday, November 8, 2023 · 12:00 p.m.
Eastern Time (US & Canada)
Duration: 1 hour
Price:Free
Language:English
Who can attend?Everyone
Dial-in available?
(listen only):Yes.
Dial-in Number:
Please register for this Webinar to view the dial-in info.
Ms. Javitt provides strategic FDA regulatory advice for leading medical device, diagnostics, pharmaceutical, biological products, and human cellular, and tissue-based products (HCT/Ps) throughout the product life cycle and has successfully...
Healthcare is broken and I would like to be a part of fixing it. I believe that the medical laboratory industry needs to be disrupted, and I spend each day advocating for the value of clinical laboratories and seeking new and more efficient ways...
We provide comprehensive solutions to challenges facing the medical laboratory community through Lab Management, Recruiting, Consulting, RCM, and Lab Director Services. Our mission is to make Quality Laboratory Testing More Accessible.